Kumamoto University researchers discover that combining two advanced heart imaging techniques can predict life-threatening ...

A routine heart scan might soon do more than just check for clogged arteries; it could act as a crystal ball for your cardiac ...

The study shows that disease severity and poor prognosis in ATTR-CM are associated with elevated levels of mid-regional ...

What if doctors could determine heart health before ever stepping into the operating room? At Kennesaw State University, ...

When the NHS rejected two new treatments for Alzheimer’s disease last year on the grounds that they are not cost-effective, ...

The FDA approved Endospan's Nexus aortic arch stent graft system, a bimodular device designed to mimic the ascending and arch ...

Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...

Higher levels of vitamin D in early midlife were associated with significantly lower levels of tau deposition 16 years later in adults without dementia.

Add Yahoo as a preferred source to see more of our stories on Google. The pathway uses the FDA-cleared echocardiography AI algorithm Us2.ai Viz.ai has entered a collaboration with Alnylam to advance ...

Editor's note: This article has been updated to clarify Ellipsis Health’s offerings. AI-backed imaging and care coordination company Viz.ai is partnering with RNAi therapeutics company Alnylam ...

Viz.ai, the leader in AI-powered disease detection and care coordination, today announced a partnership with Alnylam Pharmaceuticals, the leading RNAi therapeutics company, to accelerate early ...